# Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration

> **NCT00752882** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 24 (estimated)

## Conditions studied

- Pseudomonas Aeruginosa Meningitis

## Interventions

- **DRUG:** ceftazidime

## Key facts

- **NCT ID:** NCT00752882
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752882, "Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00752882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*